552 related articles for article (PubMed ID: 25762177)
1. De novo generation of HSCs from somatic and pluripotent stem cell sources.
Vo LT; Daley GQ
Blood; 2015 Apr; 125(17):2641-8. PubMed ID: 25762177
[TBL] [Abstract][Full Text] [Related]
2. Generating human hematopoietic stem cells in vitro -exploring endothelial to hematopoietic transition as a portal for stemness acquisition.
Slukvin II
FEBS Lett; 2016 Nov; 590(22):4126-4143. PubMed ID: 27391301
[TBL] [Abstract][Full Text] [Related]
3. Progress and obstacles towards generating hematopoietic stem cells from pluripotent stem cells.
Lee J; Dykstra B; Sackstein R; Rossi DJ
Curr Opin Hematol; 2015 Jul; 22(4):317-23. PubMed ID: 26049752
[TBL] [Abstract][Full Text] [Related]
4. Making HSCs in vitro: don't forget the hemogenic endothelium.
Blaser BW; Zon LI
Blood; 2018 Sep; 132(13):1372-1378. PubMed ID: 30089629
[TBL] [Abstract][Full Text] [Related]
5. Progress and challenges in generating functional hematopoietic stem/progenitor cells from human pluripotent stem cells.
Liu S; Xu Y; Zhou Z; Feng B; Huang H
Cytotherapy; 2015 Apr; 17(4):344-58. PubMed ID: 25680303
[TBL] [Abstract][Full Text] [Related]
6. In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells.
Hexum MK; Tian X; Kaufman DS
Methods Mol Biol; 2011; 767():433-47. PubMed ID: 21822894
[TBL] [Abstract][Full Text] [Related]
7. Generation of Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells.
Oguro H
Methods Mol Biol; 2019; 2048():245-257. PubMed ID: 31396942
[TBL] [Abstract][Full Text] [Related]
8. Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells.
Dege C; Sturgeon CM
J Vis Exp; 2017 Nov; (129):. PubMed ID: 29155741
[TBL] [Abstract][Full Text] [Related]
9. The hemogenic endothelium: a critical source for the generation of PSC-derived hematopoietic stem and progenitor cells.
Lange L; Morgan M; Schambach A
Cell Mol Life Sci; 2021 May; 78(9):4143-4160. PubMed ID: 33559689
[TBL] [Abstract][Full Text] [Related]
10. Serum- and stromal cell-free hypoxic generation of embryonic stem cell-derived hematopoietic cells in vitro, capable of multilineage repopulation of immunocompetent mice.
Lesinski DA; Heinz N; Pilat-Carotta S; Rudolph C; Jacobs R; Schlegelberger B; Klump H; Schiedlmeier B
Stem Cells Transl Med; 2012 Aug; 1(8):581-91. PubMed ID: 23197864
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells.
Slukvin II
Blood; 2013 Dec; 122(25):4035-46. PubMed ID: 24124087
[TBL] [Abstract][Full Text] [Related]
12. Two new routes to make blood: Hematopoietic specification from pluripotent cell lines versus reprogramming of somatic cells.
Singbrant S; van Galen P; Lucas D; Challen G; Rossi DJ; Daley GQ
Exp Hematol; 2015 Sep; 43(9):756-9. PubMed ID: 26143581
[TBL] [Abstract][Full Text] [Related]
13. Development of hematopoietic stem and progenitor cells from human pluripotent stem cells.
Chen T; Wang F; Wu M; Wang ZZ
J Cell Biochem; 2015 Jul; 116(7):1179-89. PubMed ID: 25740540
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives.
Demirci S; Leonard A; Tisdale JF
Stem Cells Transl Med; 2020 Dec; 9(12):1549-1557. PubMed ID: 32725882
[TBL] [Abstract][Full Text] [Related]
15. Patterning definitive hematopoietic stem cells from embryonic stem cells.
Lengerke C; Daley GQ
Exp Hematol; 2005 Sep; 33(9):971-9. PubMed ID: 16140144
[TBL] [Abstract][Full Text] [Related]
16. Converting cell fates: generating hematopoietic stem cells de novo via transcription factor reprogramming.
Daniel MG; Lemischka IR; Moore K
Ann N Y Acad Sci; 2016 Apr; 1370(1):24-35. PubMed ID: 26748878
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor-mediated reprogramming toward hematopoietic stem cells.
Ebina W; Rossi DJ
EMBO J; 2015 Mar; 34(6):694-709. PubMed ID: 25712209
[TBL] [Abstract][Full Text] [Related]
18. Autologous blood cell therapies from pluripotent stem cells.
Lengerke C; Daley GQ
Blood Rev; 2010 Jan; 24(1):27-37. PubMed ID: 19910091
[TBL] [Abstract][Full Text] [Related]
19. Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term programming.
Izawa K; Yamazaki S; Becker HJ; Bhadury J; Kakegawa T; Sakaguchi M; Tojo A
Exp Hematol; 2020 Sep; 89():68-79.e7. PubMed ID: 32795499
[TBL] [Abstract][Full Text] [Related]
20. Engineering the haemogenic niche mitigates endogenous inhibitory signals and controls pluripotent stem cell-derived blood emergence.
Rahman N; Brauer PM; Ho L; Usenko T; Tewary M; Zúñiga-Pflücker JC; Zandstra PW
Nat Commun; 2017 May; 8():15380. PubMed ID: 28541275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
